Medtronic Launches Symplicity™ Blood Pressure Procedure
New Delhi, December 22, 2023.
India Medtronic Private Limited, a wholly owned subsidiary of Medtronic plc (NYSE: MDT), announced the launch of the Symplicity™ Spyral renal denervation system (RDN) for treating high blood pressure. RDN is a minimally invasive therapy that targets nerves near the kidneys that can become overactive and cause high blood pressure. Medtronic recently announced the US Food and Drug Administration’s (FDA) approval of the system which is a culmination of ten years of clinical research and development, and the system has approval of the Indian regulatory authorities too.
In India, nearly 1 in 4 adults have hypertension.[i] Hypertension is the single largest contributor to cardiovascular death; it dramatically increases risk of heart attack, stroke,...
